GABRG2 rs735665: Understanding Epilepsy-Associated Variants
The rs735665 variant is located within the GABRG2 gene, which plays a critical role in brain signaling. This variant is studied for its potential associations with a spectrum of epilepsy syndromes, ranging from simple febrile seizures to more complex genetic epilepsy conditions.
What each genotype means
Typical GABRG2 profile
This genotype represents the most common sequence found in the general population. It is not associated with the rare pathogenic mutations in the GABRG2 gene that have been linked to epilepsy syndromes like GEFS+ or childhood absence epilepsy. Most individuals with this genotype do not have an increased genetic risk for these specific conditions based on this variant.
This is the most common genotype observed across all major global populations.
Variant carrier status
This genotype indicates the presence of one copy of the variant allele. While some GABRG2 variants are linked to epilepsy, the clinical significance of this specific rsID depends on whether it is classified as pathogenic in current databases; many variants in this gene are rare and require clinical correlation. If you have a personal or family history of seizures, please discuss these results with a neurologist or genetic counselor to determine if this finding is relevant to your health.
This genotype is rare, occurring at low frequencies that vary significantly by ancestry.
Potential variant association
This genotype indicates the presence of two copies of the variant allele. Research into GABRG2 suggests that certain variants can alter GABA receptor function, potentially contributing to seizure susceptibility or epilepsy syndromes. Because the clinical impact of GABRG2 variants can be complex and variable, this result should be reviewed by a medical professional in the context of your overall health history.
This genotype is very rare in the general population.
What is rs735665 and Where is it Located?
The rs735665 variant is a specific single nucleotide polymorphism (SNP) found within the GABRG2 gene. This gene is located on human chromosome 5 and provides the instructions for creating the gamma-2 subunit of the GABA-A receptor. GABA-A receptors are essential components of the central nervous system, acting as the primary inhibitory neurotransmitter receptors in the brain. By allowing chloride ions to flow into neurons, these receptors help dampen electrical activity, effectively acting as a 'brake' on the brain's signaling system. When a variant like rs735665 occurs, it may alter the structure or function of this receptor subunit, potentially impacting how effectively the brain can regulate its own excitability. Researchers track these specific locations in the genome to understand how minor changes in DNA sequence can contribute to the complex biological mechanisms underlying neurological health and susceptibility to seizure disorders.
The Role of the GABRG2 Gene
The GABRG2 gene is vital for the proper assembly and function of GABA-A receptors. These receptors are complex structures made of multiple subunits, and the gamma-2 subunit is particularly important for the receptor's ability to respond to benzodiazepines and maintain stability at the synapse. Because GABA-A receptors are responsible for inhibitory signaling, any disruption in the GABRG2 gene can lead to a reduction in the brain's ability to inhibit excessive electrical activity. Scientific literature has established that both loss-of-function and gain-of-function mutations in this gene can lead to a wide phenotypic spectrum. This means that different variants in the same gene can result in vastly different clinical outcomes, ranging from mild, self-limiting febrile seizures in childhood to more severe developmental and epileptic encephalopathies. Understanding the function of GABRG2 is therefore central to current research into the molecular basis of genetic epilepsies.
Research Associations and Evidence Strength
Research into GABRG2 variants has identified them as significant contributors to various epilepsy syndromes, including childhood absence epilepsy and genetic epilepsy with febrile seizures plus (GEFS+). The evidence strength for GABRG2 as a risk factor for these conditions is considered moderate to strong in the context of familial epilepsy. Studies have utilized whole-exome sequencing to identify rare coding variants in individuals with epilepsy, often finding that these variants disrupt the normal inhibitory function of the GABA-A receptor. However, the clinical picture is complex; the presence of a variant does not guarantee a specific diagnosis, as the same variant can sometimes be found in individuals with different levels of seizure severity or even in unaffected family members. This variability suggests that other genetic and environmental factors likely influence how a GABRG2 variant manifests in an individual, making it a subject of ongoing investigation in clinical neurology.
Population Frequency and Distribution
The frequency of specific GABRG2 variants like rs735665 varies significantly across different global populations. Generally, variants associated with epilepsy syndromes in this gene are considered rare or low-frequency in the general population. Because these variants are often identified through studies of families with a history of epilepsy, their prevalence in the broader, non-clinical population is typically very low. It is important to note that population databases like gnomAD provide data on the frequency of these alleles, which helps researchers distinguish between common benign variations and rare, potentially pathogenic ones. Because the frequency is low, large-scale genomic studies are often required to confirm the statistical significance of these variants in relation to specific health outcomes. If you are interested in your own genetic data, it is essential to interpret these findings within the context of your personal and family medical history.
What You Can Do With This Information
Genetic information regarding variants like rs735665 is primarily a tool for scientific research and clinical understanding rather than a diagnostic test for the general public. If you have received information about this variant from a genetic test, it is important to remember that a genetic association is not a medical diagnosis. Epilepsy is a complex condition influenced by many genes and environmental factors, and the presence of a single variant does not determine your health outcome. You cannot use this information to predict future health or to make decisions about medication. If you have concerns about seizures or neurological health, the most appropriate step is to consult with a neurologist or a genetic counselor. These professionals can help interpret your results in the context of your overall health and provide guidance on whether further clinical evaluation is necessary. Always discuss any questions about your genetic profile with a qualified healthcare provider.
How common is this variant?
The rs735665 variant is generally rare to low frequency, with its prevalence varying depending on the specific ancestral population studied.
Frequently asked questions
Is rs735665 a cause of epilepsy?
The rs735665 variant is associated with a spectrum of epilepsy syndromes, but it is not considered a direct 'cause' in the way that a single mutation might cause a strictly Mendelian disease. Epilepsy is complex, and this variant is one of many potential genetic factors that may contribute to an individual's susceptibility.
Should I be worried if I have this variant?
Finding a variant in your genetic data does not mean you will develop a condition. Many people carry genetic variants without ever experiencing health issues, as other factors play a significant role in how genes are expressed.
Can I use this information to choose medication?
No, you should never use genetic information to make decisions about medication or dosing. Always discuss your genetic results and any health concerns with your clinician or pharmacist, who can provide advice based on your full medical history.
Where can I find more information about GABRG2?
You can find reliable information about the GABRG2 gene and its role in health through resources like MedlinePlus Genetics or by searching the NCBI Gene database. These sites provide peer-reviewed, accurate summaries of gene functions and their known associations with human disease.
Sources & further reading
Educational information only, last refreshed 9/16/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs735665?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in GABRG2
This variant in the GABRG2 gene is associated with variations in response to certain anticonvulsant medications and epilepsy susceptibility.
This variant is located in the GABRG2 gene, which encodes the gamma-2 subunit of the GABA-A receptor; variants in this gene are associated with a spectrum of epilepsy syndromes.
Linked to GABA-A receptor subunit dysfunction, a known mechanism for inherited epilepsy syndromes.
A common variant in GABRG2, a gene encoding a GABA-A receptor subunit linked to various epilepsy phenotypes including febrile seizures and GEFS+.
Variant in GABRG2, a gene where mutations can alter GABA-A receptor function and influence seizure thresholds.
Mutations in GABRG2 are linked to a spectrum of epilepsy ranging from simple febrile seizures to severe developmental and epileptic encephalopathies.